(Q45143576)

10 December 2017

title

Prospective study of topical testosterone gel (AndroGel) versus intramuscular testosterone in testosterone-deficient HIV-infected men. (English)

1 reference

10 December 2017

1 reference

1 reference

James D Scott

1

1 reference

10 December 2017

Peter R Wolfe

2

1 reference

10 December 2017

Peter Anderson

3

1 reference

10 December 2017

Gary R Cohan

4

1 reference

10 December 2017

Anthony Scarsella

5

1 reference

10 December 2017

publication date

1 November 2007

1 reference

10 December 2017

1 reference

10 December 2017

volume

8

1 reference

10 December 2017

issue

6

1 reference

10 December 2017

page(s)

412-420

1 reference

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Endocrine disorders in men infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Testosterone replacement treatment options for HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

Program savings associated with switching testosterone intramuscular injections to topical gel in HIV infected males

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-412

21 January 2018

Identifiers

DOI

10.1310/HCT0806-412

1 reference

10 December 2017

1 reference